Artizan Biosciences, a biotechnology company focused on curing inflammatory bowel disease by targeting bacteria that inhabit the gastrointestinal system, is returning to its New Haven birthplace after raising $12 million.
The latest infusion of capital has enabled the startup to expand to 11 employees. more